598 related articles for article (PubMed ID: 34103079)
41. Review: experimental manipulations of microglia in mouse models of Alzheimer's pathology: activation reduces amyloid but hastens tau pathology.
Lee DC; Rizer J; Hunt JB; Selenica ML; Gordon MN; Morgan D
Neuropathol Appl Neurobiol; 2013 Feb; 39(1):69-85. PubMed ID: 23171029
[TBL] [Abstract][Full Text] [Related]
42. Sustained interleukin-1β overexpression exacerbates tau pathology despite reduced amyloid burden in an Alzheimer's mouse model.
Ghosh S; Wu MD; Shaftel SS; Kyrkanides S; LaFerla FM; Olschowka JA; O'Banion MK
J Neurosci; 2013 Mar; 33(11):5053-64. PubMed ID: 23486975
[TBL] [Abstract][Full Text] [Related]
43. Alzheimer's disease pathological lesions activate the spleen tyrosine kinase.
Schweig JE; Yao H; Beaulieu-Abdelahad D; Ait-Ghezala G; Mouzon B; Crawford F; Mullan M; Paris D
Acta Neuropathol Commun; 2017 Sep; 5(1):69. PubMed ID: 28877763
[TBL] [Abstract][Full Text] [Related]
44. Deletion of Abi3/Gngt2 influences age-progressive amyloid β and tau pathologies in distinctive ways.
Ibanez KR; McFarland KN; Phillips J; Allen M; Lessard CB; Zobel L; De La Cruz EG; Shah S; Vo Q; Wang X; Quicksall Z; Ryu D; Funk C; Ertekin-Taner N; Prokop S; Golde TE; Chakrabarty P
Alzheimers Res Ther; 2022 Jul; 14(1):104. PubMed ID: 35897046
[TBL] [Abstract][Full Text] [Related]
45. Amyloid deposition precedes tangle formation in a triple transgenic model of Alzheimer's disease.
Oddo S; Caccamo A; Kitazawa M; Tseng BP; LaFerla FM
Neurobiol Aging; 2003 Dec; 24(8):1063-70. PubMed ID: 14643377
[TBL] [Abstract][Full Text] [Related]
46. IFN-γ Production by amyloid β-specific Th1 cells promotes microglial activation and increases plaque burden in a mouse model of Alzheimer's disease.
Browne TC; McQuillan K; McManus RM; O'Reilly JA; Mills KH; Lynch MA
J Immunol; 2013 Mar; 190(5):2241-51. PubMed ID: 23365075
[TBL] [Abstract][Full Text] [Related]
47. Opposing effects of progranulin deficiency on amyloid and tau pathologies via microglial TYROBP network.
Takahashi H; Klein ZA; Bhagat SM; Kaufman AC; Kostylev MA; Ikezu T; Strittmatter SM;
Acta Neuropathol; 2017 May; 133(5):785-807. PubMed ID: 28070672
[TBL] [Abstract][Full Text] [Related]
48. The role of microglia in processing and spreading of bioactive tau seeds in Alzheimer's disease.
Hopp SC; Lin Y; Oakley D; Roe AD; DeVos SL; Hanlon D; Hyman BT
J Neuroinflammation; 2018 Sep; 15(1):269. PubMed ID: 30227881
[TBL] [Abstract][Full Text] [Related]
49. A{beta} accelerates the spatiotemporal progression of tau pathology and augments tau amyloidosis in an Alzheimer mouse model.
Hurtado DE; Molina-Porcel L; Iba M; Aboagye AK; Paul SM; Trojanowski JQ; Lee VM
Am J Pathol; 2010 Oct; 177(4):1977-88. PubMed ID: 20802182
[TBL] [Abstract][Full Text] [Related]
50. ApoE facilitates the microglial response to amyloid plaque pathology.
Ulrich JD; Ulland TK; Mahan TE; Nyström S; Nilsson KP; Song WM; Zhou Y; Reinartz M; Choi S; Jiang H; Stewart FR; Anderson E; Wang Y; Colonna M; Holtzman DM
J Exp Med; 2018 Apr; 215(4):1047-1058. PubMed ID: 29483128
[TBL] [Abstract][Full Text] [Related]
51. Ablation of TNF-RI/RII expression in Alzheimer's disease mice leads to an unexpected enhancement of pathology: implications for chronic pan-TNF-α suppressive therapeutic strategies in the brain.
Montgomery SL; Mastrangelo MA; Habib D; Narrow WC; Knowlden SA; Wright TW; Bowers WJ
Am J Pathol; 2011 Oct; 179(4):2053-70. PubMed ID: 21835156
[TBL] [Abstract][Full Text] [Related]
52. Selective targeting and modulation of plaque associated microglia via systemic hydroxyl dendrimer administration in an Alzheimer's disease mouse model.
Henningfield CM; Soni N; Lee RW; Sharma R; Cleland JL; Green KN
Alzheimers Res Ther; 2024 May; 16(1):101. PubMed ID: 38711159
[TBL] [Abstract][Full Text] [Related]
53. Molecular and functional signatures in a novel Alzheimer's disease mouse model assessed by quantitative proteomics.
Kim DK; Park J; Han D; Yang J; Kim A; Woo J; Kim Y; Mook-Jung I
Mol Neurodegener; 2018 Jan; 13(1):2. PubMed ID: 29338754
[TBL] [Abstract][Full Text] [Related]
54. Central vascular disease and exacerbated pathology in a mixed model of type 2 diabetes and Alzheimer's disease.
Ramos-Rodriguez JJ; Jimenez-Palomares M; Murillo-Carretero MI; Infante-Garcia C; Berrocoso E; Hernandez-Pacho F; Lechuga-Sancho AM; Cozar-Castellano I; Garcia-Alloza M
Psychoneuroendocrinology; 2015 Dec; 62():69-79. PubMed ID: 26254770
[TBL] [Abstract][Full Text] [Related]
55. Amyloid cored plaques in Tg2576 transgenic mice are characterized by giant plaques, slightly activated microglia, and the lack of paired helical filament-typed, dystrophic neurites.
Sasaki A; Shoji M; Harigaya Y; Kawarabayashi T; Ikeda M; Naito M; Matsubara E; Abe K; Nakazato Y
Virchows Arch; 2002 Oct; 441(4):358-67. PubMed ID: 12404061
[TBL] [Abstract][Full Text] [Related]
56. Amyloid β and Tau Alzheimer's disease related pathology is reduced by Toll-like receptor 9 stimulation.
Scholtzova H; Chianchiano P; Pan J; Sun Y; Goñi F; Mehta PD; Wisniewski T
Acta Neuropathol Commun; 2014 Sep; 2():101. PubMed ID: 25178404
[TBL] [Abstract][Full Text] [Related]
57. Partial reduction of microglia does not affect tau pathology in aged mice.
Bennett RE; Bryant A; Hu M; Robbins AB; Hopp SC; Hyman BT
J Neuroinflammation; 2018 Nov; 15(1):311. PubMed ID: 30413160
[TBL] [Abstract][Full Text] [Related]
58. Dysfunctional microglia and tau pathology in Alzheimer's disease.
Ayyubova G
Rev Neurosci; 2023 Jun; 34(4):443-458. PubMed ID: 36302379
[TBL] [Abstract][Full Text] [Related]
59. Inhibition of IL-34 Unveils Tissue-Selectivity and Is Sufficient to Reduce Microglial Proliferation in a Model of Chronic Neurodegeneration.
Obst J; Simon E; Martin-Estebane M; Pipi E; Barkwill LM; Gonzalez-Rivera I; Buchanan F; Prescott AR; Faust D; Fox S; Brownlees J; Taylor D; Perry VH; Nuthall H; Atkinson PJ; Karran E; Routledge C; Gomez-Nicola D
Front Immunol; 2020; 11():579000. PubMed ID: 33162994
[TBL] [Abstract][Full Text] [Related]
60. Relationship between ubiquilin-1 and BACE1 in human Alzheimer's disease and APdE9 transgenic mouse brain and cell-based models.
Natunen T; Takalo M; Kemppainen S; Leskelä S; Marttinen M; Kurkinen KMA; Pursiheimo JP; Sarajärvi T; Viswanathan J; Gabbouj S; Solje E; Tahvanainen E; Pirttimäki T; Kurki M; Paananen J; Rauramaa T; Miettinen P; Mäkinen P; Leinonen V; Soininen H; Airenne K; Tanzi RE; Tanila H; Haapasalo A; Hiltunen M
Neurobiol Dis; 2016 Jan; 85():187-205. PubMed ID: 26563932
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
